Molecular Partners Ag

Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference

Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting